These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21272758)

  • 1. CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach.
    Moynagh AM; Scott DJ; Baumbach A; Khavandi A; Brecker SJ; Laborde JC; Brown S; Chowdhary S; Saravanan D; Crean PA; Teehan S; Hildick-Smith D; Trivedi U; Khogali SS; Bhabra MS; Roberts DH; Morgan KP; Blackman DJ;
    J Am Coll Cardiol; 2011 Feb; 57(5):634-5. PubMed ID: 21272758
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system.
    Petronio AS; De Carlo M; Bedogni F; Marzocchi A; Klugmann S; Maisano F; Ramondo A; Ussia GP; Ettori F; Poli A; Brambilla N; Saia F; De Marco F; Colombo A
    Circ Cardiovasc Interv; 2010 Aug; 3(4):359-66. PubMed ID: 20606135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis.
    Attias D; Himbert D; Ducrocq G; Détaint D; Al-Attar N; Iung B; Francis F; Maury JM; Brochet E; Enguerrand D; Nataf P; Vahanian A
    Arch Cardiovasc Dis; 2010 Apr; 103(4):236-45. PubMed ID: 20656634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous aortic valve implantation using the axillary/subclavian access: feasibility and early clinical outcomes.
    Modine T; Obadia JF; Choukroun E; Rioufoul G; Sudre A; Laborde JC; Leprince P
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):487-91, 491.e1. PubMed ID: 20434180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications.
    Guinot PG; Depoix JP; Etchegoyen L; Benbara A; Provenchère S; Dilly MP; Philip I; Enguerand D; Ibrahim H; Vahanian A; Himbert D; Al-Attar N; Nataf P; Desmonts JM; Montravers P; Longrois D
    J Cardiothorac Vasc Anesth; 2010 Oct; 24(5):752-61. PubMed ID: 20188592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety.
    Johansson M; Nozohoor S; Kimblad PO; Harnek J; Olivecrona GK; Sjögren J
    Ann Thorac Surg; 2011 Jan; 91(1):57-63. PubMed ID: 21172486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches.
    Rodés-Cabau J; Dumont E; Boone RH; Larose E; Bagur R; Gurvitch R; Bédard F; Doyle D; De Larochellière R; Jayasuria C; Villeneuve J; Marrero A; Côté M; Pibarot P; Webb JG
    J Am Coll Cardiol; 2011 Jan; 57(1):18-28. PubMed ID: 21185496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous transfemoral aortic CoreValve(R) implantations in high risk patients--another Polish good experience].
    Wilczek K; Chodór P; Laborde JC; Przybylski R; Krasoń M; Niklewski T; Głowacki J; Nadziakiewicz P; Kusa J; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2009 Oct; 67(10):1162-5. PubMed ID: 20017087
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team.
    Bleiziffer S; Ruge H; Mazzitelli D; Schreiber C; Hutter A; Laborde JC; Bauernschmitt R; Lange R
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):615-20; discussion 620-1. PubMed ID: 19233669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools & techniques: transcatheter aortic valve implantation: transfemoral approach.
    Himbert D; Roy D; Brecker S; Brochet E; Depoix JP; Radu C; Laborde JC; Vahanian A
    EuroIntervention; 2011 Jan; 6(6):784-5. PubMed ID: 21205606
    [No Abstract]   [Full Text] [Related]  

  • 12. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
    Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
    Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of implant failure during transcatheter aortic valve implantation.
    Ussia GP; Barbanti M; Immè S; Scarabelli M; Mulè M; Cammalleri V; Aruta P; Pistritto AM; Capodanno D; Deste W; Di Pasqua MC; Tamburino C
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):440-9. PubMed ID: 20506152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subclavian artery access for transcatheter aortic valve implantation].
    Santos N; Caeiro D; Mota J; Braga P; Gonçalves M; Gama V; Vouga L
    Rev Port Cir Cardiotorac Vasc; 2009; 16(2):71-6. PubMed ID: 19823703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation?
    Saia F; Marrozzini C; Dall'Ara G; Russo V; Martìn-Suàrez S; Savini C; Ortolani P; Palmerini T; Taglieri N; Bordoni B; Pilato E; Di Bartolomeo R; Branzi A; Marzocchi A
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):727-32. PubMed ID: 20414120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous aortic valve replacement in patients with challenging aortoiliofemoral access.
    Jilaihawi H; Spyt T; Chin D; Logtens E; Laborde JC; Kovac J
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):885-90. PubMed ID: 18798235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report.
    Ruge H; Lange R; Bleiziffer S; Hutter A; Mazzitelli D; Will A; Schreiber C; Laborde JC; Bauernschmitt R
    Heart Surg Forum; 2008; 11(5):E323-4. PubMed ID: 18948247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates.
    ElBardissi AW; Shekar P; Couper GS; Cohn LH
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):328-35. PubMed ID: 21047646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical and transcatheter aortic valve procedures. The limits of risk scores.
    Ranucci M; Guarracino F; Castelvecchio S; Baldassarri R; Covello RD; Landoni G;
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):138-41. PubMed ID: 20484408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients.
    Bauernschmitt R; Schreiber C; Bleiziffer S; Ruge H; Mazzitelli D; Hutter A; Tassani P; Lange R
    Heart Surg Forum; 2009 Jan; 12(1):E63-4. PubMed ID: 19233771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.